Cover Image
Market Research Report

U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Type (Laser, Directional, Rotational, Orbital), By End Use (Office-based Labs, Out-patient Facility, In-patient Facility), And Segment Forecasts, 2019 - 2025

Published by Grand View Research, Inc. Product code 909165
Published Content info 90 Pages
Delivery time: 2-3 business days
Price
Back to Top
U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Type (Laser, Directional, Rotational, Orbital), By End Use (Office-based Labs, Out-patient Facility, In-patient Facility), And Segment Forecasts, 2019 - 2025
Published: February 7, 2019 Content info: 90 Pages
Description

The U.S. atherectomy devices market size is expected to reach USD 626.1 million by 2025 expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. The regional market is expected to witness lucrative growth due to the rising prevalence of target diseases and preference for endovascular procedures. Moreover, rising demand for minimally invasive procedure will boost the market growth. Such procedures are less painful and allow quicker recovery than invasive procedures.

Other advantages, such as higher patient satisfaction owing to fewer incision wounds, few post-surgical complications, and low mortality rates, are also driving the atherectomy devices market growth. Technological advancements allowing early diagnosis are also likely to augment the market growth in the near future. For instance, in January 2017, Medtronic received CE mark approval for HawkOne directional atherectomy system for treating patients suffering from Peripheral Artery Disease (PAD).

Further key findings from the study suggest:

  • Adoption of atherectomy increased sharply in the past due to increased reimbursement for the procedure. According to Elsevier Inc., there was a rise in atherectomy volume for Medicare beneficiaries to 76% in 2011-2015
  • Directional atherectomy devices accounted for the largest share of the market in 2017 as the device exhibited 95% successful removal of lesions and 94% of patients did not exhibit adverse effects
  • Office-Based Labs (OBLs) is anticipated to be the fastest-growing segment in the forecast period due to a greater number of Peripheral Vascular Interventional (PVI) procedures being performed in this setting
  • In addition, lesser number of complications and follow-up procedures lowers the cost and increases the adoption of new technologies delivering better health outcomes, which is anticipated to propel the market growth in the coming years
  • Several ongoing trials and their positive results facilitate penetration of novel technologies. For instance, in March 2017, Cardiovascular Systems, Inc. enrolled for its latest clinical trial, ECLIPSE, which was perceived to be the largest trial conducted to study coronary atherectomy

Some of the key companies are: Spectranetics Corp.; Boston Scientific Corp.; Cardinal Health, Inc.; Straub Medical AG; Terumo Medical Corp.; Cardiovascular Systems, Inc.; Medtronic PLC; Avinger, Inc.; ST. JUDE MEDICAL, Inc.

Table of Contents
Product Code: GVR-2-68038-799-5

Table of Contents

Chapter 1: Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2: Executive Summary

  • 2.1 Market Snapshot

Chapter 3: Market Variables, Trends & Scope

  • 3.1 Market Segmentation and Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Increasing prevalence of target diseases
      • 3.1.1.2 Preference to minimally invasive procedures
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Lack of level 1 evidence for atherectomy
      • 3.1.2.2 Lack of technical training for the procedure
      • 3.1.2.3 Significant adoption of alternative therapies
  • 3.2 Penetration & Growth Prospects Mapping
  • 3.3 U.S. Atherectomy Devices Market - PESTLE Analysis
  • 3.4 Industry Analysis - Porter's
  • 3.5 U.S. Atherectomy Devices: Regulatory Scenario
  • 3.6 U.S. Atherectomy Devices Market: Reimbursement Scenario
  • 3.7 Key Clinical Trials & Studies
    • 3.7.1 Opinions/Views on Key Clinical Trials and Their Impact on the Market and Customer
  • 3.8 U.S. Peripheral Atherectomy: Number of Procedures

Chapter 4: U.S. Atherectomy Devices Market: Type Estimates & Trend Analysis

  • 4.1 U.S. Atherectomy Devices Market: Type Movement Analysis
  • 4.2 Directional Atherectomy Devices
    • 4.2.1 Directional atherectomy devices market, 2014 - 2025 (USD Million)
  • 4.3 Rotational Atherectomy Devices
    • 4.3.1 Rotational atherectomy market, 2014 - 2025 (USD Million)
  • 4.4 Orbital Atherectomy Devices
    • 4.4.1 Orbital atherectomy devices market, 2014 - 2025 (USD Million)
  • 4.5 Laser Atherectomy Devices
    • 4.5.1 Laser atherectomy devices market, 2014 - 2025 (USD Million)

Chapter 5: U.S. Atherectomy Devices Market: End Use Estimates & Trend Analysis

  • 5.1 U.S. Atherectomy Devices Market: End Use Movement Analysis
  • 5.2 In-Patient Facility
    • 5.2.1 In-patient facility market, 2014 - 2025 (USD Million)
  • 5.3 Office-Based Labs (OBLs)
    • 5.3.1 Office-based labs (OBLs) market, 2014 - 2025 (USD Million)
  • 5.4 Out-Patient facility
    • 5.4.1 Out-patient facility, 2014 - 2025 (USD Million)

Chapter 6: Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Competitive Landscape: Market Position Analysis
  • 6.3 Company Profiles
    • 6.3.1 Boston Scientific Corporation
      • 6.3.1.1 Company overview
      • 6.3.1.2 Financial performance
      • 6.3.1.3 SWOT analysis
      • 6.3.1.4 Product benchmarking
      • 6.3.1.5 Strategic initiatives
    • 6.3.2 Cardiovascular Systems, Inc.
      • 6.3.2.1 Company overview
      • 6.3.2.2 Financial performance
      • 6.3.2.3 SWOT analysis
      • 6.3.2.4 Product benchmarking
      • 6.3.2.5 Strategic initiatives
    • 6.3.3 Medtronic
      • 6.3.3.1 Company overview
      • 6.3.3.2 Financial performance
      • 6.3.3.3 SWOT analysis
      • 6.3.3.4 Product benchmarking
      • 6.3.3.5 Strategic initiatives
    • 6.3.4 Spectranetics
      • 6.3.4.1 Company overview
      • 6.3.4.2 Financial performance
      • 6.3.4.3 SWOT analysis
      • 6.3.4.4 Product benchmarking
      • 6.3.4.5 Strategic initiatives
    • 6.3.5 Avinger
      • 6.3.5.1 Company overview
      • 6.3.5.2 Financial performance
      • 6.3.5.3 Product benchmarking
      • 6.3.5.4 Strategic initiatives
    • 6.3.6 ST. JUDE MEDICAL
      • 6.3.6.1 Company overview
      • 6.3.6.2 Financial performance
      • 6.3.6.3 SWOT analysis
      • 6.3.6.4 Product benchmarking
    • 6.3.7 Cardinal Health (Cordis)
      • 6.3.7.1 Company overview
      • 6.3.7.2 Financial performance
      • 6.3.7.3 SWOT analysis
      • 6.3.7.4 Product benchmarking
      • 6.3.7.5 Strategic initiatives
    • 6.3.8 Terumo Medical Corporation
      • 6.3.8.1 Company overview
      • 6.3.8.2 Financial performance
      • 6.3.8.3 SWOT analysis
      • 6.3.8.4 Product benchmarking
      • 6.3.8.5 Strategic initiatives

Chapter 7: Recommendations

  • 7.1 KOL Views
  • 7.2 Recommendations

List of Tables

  • TABLE 1: Atherectomy devices comparison
  • TABLE 2: Comparison of cutting balloon angioplasty vs rotational atherectomy
  • TABLE 3: Procedure codes and physician reimbursement for endovascular procedures, 2018
  • TABLE 4: Ambulatory surgery center reimbursement for endovascular procedures, 2018
  • TABLE 5: Medicare national average payments, 2017
  • TABLE 6: Medicare reimbursement by clinical setting, 2016
  • TABLE 7: Medicare reimbursement comparison, 2014
  • TABLE 8: Patient selection criteria
  • TABLE 9: Patient selection criteria
  • TABLE 10: Patient selection criteria
  • TABLE 11: List of in-patient facility performing atherectomy in the U.S.
  • TABLE 12: Top five states performing endovascular procedures including atherectomy in OBLs, 2016

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value chain-based sizing & forecasting
  • FIG. 6: QFD modeling for market share assessment
  • FIG. 7: Market summary 2018 (USD Million)
  • FIG. 8: Market trends & outlook
  • FIG. 9: Market segmentation & scope
  • FIG. 10: Market driver relevance analysis (Current & future impact)
  • FIG. 11: Prevalence of PAD (%) by age group (years), 2016
  • FIG. 12: Market restraint relevance analysis (Current &future impact)
  • FIG. 13: Penetration & growth prospect mapping
  • FIG. 14: U.S. atherectomy devices market - PESTLE analysis
  • FIG. 15: Porter's Five Forces Analysis
  • FIG. 16: U.S. atherectomy devices market type outlook key takeaways
  • FIG. 17: U.S. atherectomy devices: Type movement analysis
  • FIG. 18: Directional atherectomy devices market, 2014 - 2025 (USD Million)
  • FIG. 19: Above knee atherosclerosis
  • FIG. 20: Below knee atherosclerosis
  • FIG. 21: Rotational atherectomy market, 2014 - 2025 (USD Million)
  • FIG. 22: Orbital atherectomy devices market, 2014 - 2025 (USD Million)
  • FIG. 23: Laser atherectomy devices market, 2014 - 2025 (USD Million)
  • FIG. 24: U.S. atherectomy devices market end-use outlook key takeaways
  • FIG. 25: U.S. atherectomy devices: End-use movement analysis
  • FIG. 26: In-patient facility market, 2014 - 2025 (USD Million)
  • FIG. 27: Office-based labs (OBLs) market, 2014 - 2025 (USD Million)
  • FIG. 28: Out-patient facility market, 2014 - 2025 (USD Million)
  • FIG. 29: Strategy framework
  • FIG. 30: U.S. atherectomy devices market: Heat map analysis
Back to Top